Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 14, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8EE5 | 8EE5 | Crystal structure of a NHP anti-ZIKV neutralizing antibody rhMZ119-D in complex with ZIKV E glycoprotein | |
| 8EE5 | A0A024B7W1 | Crystal structure of a NHP anti-ZIKV neutralizing antibody rhMZ119-D in complex with ZIKV E glycoprotein | |
| 8EDW | Q8IZY2 | Cryo-EM Structure of human ABCA7 in BPL/Ch Nanodiscs | |
| 8EDK | P34710 | Structure of C. elegans UNC-6 LamN and EGF domains | |
| 8EDI | Q26261 | Structure of C. elegans UNC-5 IG 1+2 Domains bound to Heparin dp4 | |
| 8EDF | P0DTC2 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOX5 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | 8EDF | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOX5 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | 8EDF | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOY2 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOY2 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDC | Q26261 | Structure of C. elegans UNC-5 IG 1+2 Domains | |
| 8ECW | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 11 | |
| 8E99 | Q05586 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
| 8E99 | Q12879 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
| 8E99 | Q14957 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
| 8E99 | 8E99 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
| 8E98 | Q05586 | D-cycloserine and glutamate bound Human GluN1a-GluN2C NMDA receptor in nanodisc - intact conformation | |
| 8E98 | Q14957 | D-cycloserine and glutamate bound Human GluN1a-GluN2C NMDA receptor in nanodisc - intact conformation | |
| 8E97 | Q05586 | PYD-106-bound Human GluN1a-GluN2C NMDA receptor in splayed conformation | |
| 8E97 | Q14957 | PYD-106-bound Human GluN1a-GluN2C NMDA receptor in splayed conformation | |
| 8E96 | Q05586 | Glycine and glutamate bound Human GluN1a-GluN2D NMDA receptor | |
| 8E96 | O15399 | Glycine and glutamate bound Human GluN1a-GluN2D NMDA receptor | |
| 8E94 | Q05586 | PYD-106-bound Human GluN1a-GluN2C NMDA receptor in intact conformation | |
| 8E94 | Q14957 | PYD-106-bound Human GluN1a-GluN2C NMDA receptor in intact conformation | |
| 8E93 | Q05586 | D-cycloserine and glutamate bound Human GluN1a-GluN2C NMDA receptor in splayed conformation | |
| 8E93 | Q14957 | D-cycloserine and glutamate bound Human GluN1a-GluN2C NMDA receptor in splayed conformation | |
| 8E92 | Q05586 | D-cycloserine and glutamate bound Human GluN1a-GluN2C NMDA receptor in intact conformation | |
| 8E92 | Q14957 | D-cycloserine and glutamate bound Human GluN1a-GluN2C NMDA receptor in intact conformation | |
| 8E7M | Q9BYF1 | Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04 | |
| 8E7M | 8E7M | Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04 | |
| 8E6K | Q9IGQ6 | 2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1) | |
| 8E6K | 8E6K | 2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1) | |
| 8E6G | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 10 | |
| 8E5U | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 9 | |
| 8E5B | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5B | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54284 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E5A | P54289 | Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution | |
| 8E59 | Q01668 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54284 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E59 | P54289 | Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution | |
| 8E58 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E58 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E58 | P13806 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution | |
| 8E57 | P07293 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution | |
| 8E57 | P19518 | Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution |
